Cargando…
Triterpenoids Display Single Agent Anti-tumor Activity in a Transgenic Mouse Model of Chronic Lymphocytic Leukemia and Small B Cell Lymphoma
BACKGROUND: The synthetic triterpenoid 2-Cyano-3,12-Dioxooleana-1,9-Dien-28-Oic Acid (CDDO) and derivatives display anti-tumor activity against a variety of cultured tumor cell lines and in mouse xenografts. In this report, we have studied the effects of CDDO and its imidazolide derivative (CDDO-Im)...
Autores principales: | Kress, Christina L., Konopleva, Marina, Martínez-García, Vanesa, Krajewska, Maryla, Lefebvre, Sophie, Hyer, Marc L., McQueen, Teresa, Andreeff, Michael, Reed, John C., Zapata, Juan M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1891436/ https://www.ncbi.nlm.nih.gov/pubmed/17593960 http://dx.doi.org/10.1371/journal.pone.0000559 |
Ejemplares similares
-
Effects of PPARγ Ligands on Leukemia
por: Tabe, Yoko, et al.
Publicado: (2012) -
Mitochondrial Profiling of Acute Myeloid Leukemia in the Assessment of Response to Apoptosis Modulating Drugs
por: Ishizawa, Jo, et al.
Publicado: (2015) -
Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34(+) proliferating and quiescent chronic myeloid leukemia blast crisis cells
por: Carter, Bing Z., et al.
Publicado: (2015) -
Tumor Trp53 status and genotype affect the bone marrow microenvironment in acute myeloid leukemia
por: Jacamo, Rodrigo, et al.
Publicado: (2017) -
Inhibition of Tumor Growth Using Salmonella Expressing Fas Ligand
por: Loeffler, Markus, et al.
Publicado: (2008)